Legislative Research: NJ A3 | 2016-2017 | Regular Session
Other Sessions
| Session | Title/Description | Last Action |
|---|---|---|
| 2022-2023 Regular Session (Introduced - Dead) | Revises income eligibility criteria for, and provides for promotion of, PAAD and Senior Gold Prescription Discount Program; establishes "Senior Save Navigator Grant Program" to assist applicants with NJ Save applications. [A3 2022 Detail][A3 2022 Text][A3 2022 Comments] | 2023-06-30 Substituted by S3 (2R) |
| 2020-2021 Regular Session (Passed) | Amends and supplements FY20 appropriations act to effectuate extension of fiscal year through September 30, 2020; reduces authorized appropriations; makes FY20 supplemental appropriations of $7,745,997,000 in State funds and $4,586,243,000 in federal... [A3 2020 Detail][A3 2020 Text][A3 2020 Comments] | 2020-06-30 Approved P.L.2020, c.43. |
| 2016-2017 Regular Session (Introduced - Dead) | Requires health insurance coverage for treatment of substance use disorders; places certain restrictions on the prescription of opioid and certain other drugs; concerns continuing education related thereto. [A3 2016 Detail][A3 2016 Text][A3 2016 Comments] | 2017-02-15 Substituted by S3 (1R) |
References Online
Legislative Citation
APA
NJ A3 | 2016-2017 | Regular Session. (2017, February 15). LegiScan. Retrieved May 06, 2024, from https://legiscan.com/NJ/bill/A3/2016
MLA
"NJ A3 | 2016-2017 | Regular Session." LegiScan. LegiScan LLC, 15 Feb. 2017. Web. 06 May. 2024. <https://legiscan.com/NJ/bill/A3/2016>.
Chicago
"NJ A3 | 2016-2017 | Regular Session." February 15, 2017 LegiScan. Accessed May 06, 2024. https://legiscan.com/NJ/bill/A3/2016.
Turabian
LegiScan. NJ A3 | 2016-2017 | Regular Session. 15 February 2017. https://legiscan.com/NJ/bill/A3/2016 (accessed May 06, 2024).
Subjects
Same As/Similar To
| Bill | Relationship | Date | Title | Last Action |
|---|---|---|---|---|
| S3 | Same As | 2017-02-15 | Requires health insurance coverage for treatment of substance use disorders; places certain restrictions on the prescription of opioid and certain other drugs; concerns continuing education related thereto. | Approved P.L.2017, c.28. |
